Selected research
Industry Research
Coartem (Artemether & Lumefantrine) Industry Research Report 2026
Market perspective
The global Coartem (Artemether & Lumefantrine) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Coartem (Artemether & Lumefantrine) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Coartem (Artemether & Lumefantrine) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Coartem (Artemether & Lumefantrine) include Novartis, Kunming Pharmaceutical, Kerui Nanhai Pharmaceutical, Guilin Pharmaceutical Co., Ltd, Guangxi Xiancaotang Pharmaceutical Co., LTD, Sanofi-Aventis and KPC Pharmaceuticals, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Coartem (Artemether & Lumefantrine) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coartem (Artemether & Lumefantrine) Market by Company
Novartis
Kunming Pharmaceutical
Kerui Nanhai Pharmaceutical
Guilin Pharmaceutical Co., Ltd
Guangxi Xiancaotang Pharmaceutical Co., LTD
Sanofi-Aventis
KPC Pharmaceuticals, Inc
Coartem (Artemether & Lumefantrine) Segment by Type
Artemether
Lumefantrine
Coartem (Artemether & Lumefantrine) Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Coartem (Artemether & Lumefantrine) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coartem (Artemether & Lumefantrine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coartem (Artemether & Lumefantrine) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coartem (Artemether & Lumefantrine).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Coartem (Artemether & Lumefantrine) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Coartem (Artemether & Lumefantrine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artemether
- Lumefantrine
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Companies covered
- Novartis
- Kunming Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Guilin Pharmaceutical Co., Ltd
- Guangxi Xiancaotang Pharmaceutical Co., LTD
- Sanofi-Aventis
- KPC Pharmaceuticals, Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Coartem (Artemether & Lumefantrine) Market Size (2021-2032)
- 2.2.2 Global Coartem (Artemether & Lumefantrine) Sales (2021-2032)
- 2.2.3 Global Coartem (Artemether & Lumefantrine) Market Average Price (2021-2032)
- 2.3 Coartem (Artemether & Lumefantrine) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Artemether
- 2.3.3 Lumefantrine
- 2.4 Coartem (Artemether & Lumefantrine) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Coartem (Artemether & Lumefantrine) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Coartem (Artemether & Lumefantrine) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Coartem (Artemether & Lumefantrine) Revenue of Manufacturers (2021-2026)
- 3.4 Global Coartem (Artemether & Lumefantrine) Average Price by Manufacturers (2021-2026)
- 3.5 Global Coartem (Artemether & Lumefantrine) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Coartem (Artemether & Lumefantrine), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Coartem (Artemether & Lumefantrine), Product Type & Application
- 3.8 Global Manufacturers of Coartem (Artemether & Lumefantrine), Established Date
- 3.9 Global Coartem (Artemether & Lumefantrine) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Kunming Pharmaceutical
- 4.2.1 Kunming Pharmaceutical Company Information
- 4.2.2 Kunming Pharmaceutical Business Overview
- 4.2.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.2.5 Kunming Pharmaceutical Recent Developments
- 4.3 Kerui Nanhai Pharmaceutical
- 4.3.1 Kerui Nanhai Pharmaceutical Company Information
- 4.3.2 Kerui Nanhai Pharmaceutical Business Overview
- 4.3.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.3.5 Kerui Nanhai Pharmaceutical Recent Developments
- 4.4 Guilin Pharmaceutical Co., Ltd
- 4.4.1 Guilin Pharmaceutical Co., Ltd Company Information
- 4.4.2 Guilin Pharmaceutical Co., Ltd Business Overview
- 4.4.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.4.5 Guilin Pharmaceutical Co., Ltd Recent Developments
- 4.5 Guangxi Xiancaotang Pharmaceutical Co., LTD
- 4.5.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information
- 4.5.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview
- 4.5.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.5.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments
- 4.6 Sanofi-Aventis
- 4.6.1 Sanofi-Aventis Company Information
- 4.6.2 Sanofi-Aventis Business Overview
- 4.6.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.6.5 Sanofi-Aventis Recent Developments
- 4.7 KPC Pharmaceuticals, Inc
- 4.7.1 KPC Pharmaceuticals, Inc Company Information
- 4.7.2 KPC Pharmaceuticals, Inc Business Overview
- 4.7.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio
- 4.7.5 KPC Pharmaceuticals, Inc Recent Developments
5 Global Coartem (Artemether & Lumefantrine) Market Scenario by Region
- 5.1 Global Coartem (Artemether & Lumefantrine) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021-2032
- 5.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021-2026
- 5.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2027-2032
- 5.3 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2021-2032
- 5.3.1 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2021-2026
- 5.3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2027-2032
- 5.4 North America Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country
- 5.4.1 North America Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
- 5.4.3 North America Coartem (Artemether & Lumefantrine) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country
- 5.5.1 Europe Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
- 5.5.3 Europe Coartem (Artemether & Lumefantrine) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Coartem (Artemether & Lumefantrine) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country
- 5.7.1 South America Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
- 5.7.3 South America Coartem (Artemether & Lumefantrine) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
- 6.1.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2032)
- 6.2 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
- 6.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2032)
- 6.3 Global Coartem (Artemether & Lumefantrine) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
- 7.1.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2032)
- 7.2 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
- 7.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2032)
- 7.3 Global Coartem (Artemether & Lumefantrine) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Coartem (Artemether & Lumefantrine) Value Chain Analysis
- 8.1.1 Coartem (Artemether & Lumefantrine) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Coartem (Artemether & Lumefantrine) Production Mode & Process
- 8.2 Coartem (Artemether & Lumefantrine) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Coartem (Artemether & Lumefantrine) Distributors
- 8.2.3 Coartem (Artemether & Lumefantrine) Customers
9 Global Coartem (Artemether & Lumefantrine) Analyzing Market Dynamics
- 9.1 Coartem (Artemether & Lumefantrine) Industry Trends
- 9.2 Coartem (Artemether & Lumefantrine) Industry Drivers
- 9.3 Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges
- 9.4 Coartem (Artemether & Lumefantrine) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst